Helen Torley







I love this NBU bashing! Primary Care? Hardly. They discuss very complicated disease states (Secondary Hyperparathyroidism anyone?)that affect extremely sick patients. Go into a dialysis center sometime and see how far away from Primary Care the environment is. And last time I checked, the success of EPOGEN is solely what made the other BUs even possible.

Yes, they are currently in a slump because of the declining ESA market. Remember a few years ago, the OBU was all but dead in the water. One drug changed all that (Xgeva) and yes, things are looking good. Give the NBU the next Xgeva and yes, they will rise to the top again.

At any rate, there's no need to bash. All the BUs have great products, talented sales reps etc.
 






I love this NBU bashing! Primary Care? Hardly. They discuss very complicated disease states (Secondary Hyperparathyroidism anyone?)that affect extremely sick patients. Go into a dialysis center sometime and see how far away from Primary Care the environment is. And last time I checked, the success of EPOGEN is solely what made the other BUs even possible.

Yes, they are currently in a slump because of the declining ESA market. Remember a few years ago, the OBU was all but dead in the water. One drug changed all that (Xgeva) and yes, things are looking good. Give the NBU the next Xgeva and yes, they will rise to the top again.

At any rate, there's no need to bash. All the BUs have great products, talented sales reps etc.

Well said!!
 




































I love this NBU bashing! Primary Care? Hardly. They discuss very complicated disease states (Secondary Hyperparathyroidism anyone?)that affect extremely sick patients. Go into a dialysis center sometime and see how far away from Primary Care the environment is. And last time I checked, the success of EPOGEN is solely what made the other BUs even possible.

Yes, they are currently in a slump because of the declining ESA market. Remember a few years ago, the OBU was all but dead in the water. One drug changed all that (Xgeva) and yes, things are looking good. Give the NBU the next Xgeva and yes, they will rise to the top again.

At any rate, there's no need to bash. All the BUs have great products, talented sales reps etc.

Seriously? That is not complex on any level. NBU is the bottem of the bucket filled with hack PC reps from big Pharma who thought Amgen was a "biotech". Total losers. Sorry to bash but it's true.
 












She couldnt manage out of a paper bag. When Mike N. left the whole place went to hell. He should have been the next CEO but was passed over by a big pharma nothing George. Kevin is getting out with over a 100 million in the bank. What did he do to get this kind of money?
 






Seriously? That is not complex on any level. NBU is the bottem of the bucket filled with hack PC reps from big Pharma who thought Amgen was a "biotech". Total losers. Sorry to bash but it's true.

Then please, since it's so simple - go ahead and describe what Secondary Hyperparathyroidism is and why it's bad for dialysis patients.
 






Then please, since it's so simple - go ahead and describe what Secondary Hyperparathyroidism is and why it's bad for dialysis patients.

OK I will side with the OBU’s on this one. Oncology is a million times more complex than nephrology. A low blood calcium level due to PTH excretion is nothing compared to the multitude of issues a cancer patient is dealing with both from the disease that the various treatments like surgery, radiation, systemic chemo, targeted therapies, supportive and palliative therapies, etc. Dialysis and kidney failure is a fairly straight forward disease. It’s pretty linear, failing kidneys can’t convert VitD, which can lead to a cascade of issue like pancreatitis. Anything malady where the first step in treatment is dietary restrictions is not all that complex. Sorry but you just proved that you are stupid if you think SHPT is some complex, hard to grasp and treat medical condition. Now go back to the kiddie pool with the rest of the NBU hacks…
 






OK I will side with the OBU’s on this one. Oncology is a million times more complex than nephrology. A low blood calcium level due to PTH excretion is nothing compared to the multitude of issues a cancer patient is dealing with both from the disease that the various treatments like surgery, radiation, systemic chemo, targeted therapies, supportive and palliative therapies, etc. Dialysis and kidney failure is a fairly straight forward disease. It’s pretty linear, failing kidneys can’t convert VitD, which can lead to a cascade of issue like pancreatitis. Anything malady where the first step in treatment is dietary restrictions is not all that complex. Sorry but you just proved that you are stupid if you think SHPT is some complex, hard to grasp and treat medical condition. Now go back to the kiddie pool with the rest of the NBU hacks…

I have been in both nephrology and oncology. I need to tell you its about the same. Neph is much harder when it comes to seeing doctors due to the fact they make rounds at different locations office, hospital, dialysis and ltac . Oncology is getting difficult to see without a lunch. As a disease state neph is straight forward. Oncology can be complex but not difficult.
I know the divisons like to say which is better but right now its the same. Same crappy management, same crappy marketing, same crappy contracts, and same crappy role plays. The company has never been the same since Kevin took over as CEO.
 






Most of the people who post these messages have been with AMGEN less than 5 years. Guess what? It doesn't matter which business unit you are in because you all have the same compensation, stock, benefits, etc. You can fool yourself into thinking one business unit is better than another, but the truth is it doesn't matter. You won't get rich selling for any of the business units. You can make a living and that's about it. So if it makes you feel better to bash your peers in another business unit, go ahead. The smartest people worked for AMGEN many years ago and have long since retired.
 






Most of the people who post these messages have been with AMGEN less than 5 years. Guess what? It doesn't matter which business unit you are in because you all have the same compensation, stock, benefits, etc. You can fool yourself into thinking one business unit is better than another, but the truth is it doesn't matter. You won't get rich selling for any of the business units. You can make a living and that's about it. So if it makes you feel better to bash your peers in another business unit, go ahead. The smartest people worked for AMGEN many years ago and have long since retired.

well said, couldn't agree more.